CENTRAL NERVOUS SYSTEM NEOPLASM
Clinical trials for CENTRAL NERVOUS SYSTEM NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new CENTRAL NERVOUS SYSTEM NEOPLASM trials appear
Sign up with your email to follow new studies for CENTRAL NERVOUS SYSTEM NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with rare cancers: drug blocks tumor growth
Disease control OngoingThis study tests a daily pill called cabozantinib in children and young adults (up to age 30) with rare cancers like sarcomas, Wilms tumor, and others that have come back or not responded to treatment. The drug works by blocking signals that help tumors grow and form blood vessel…
Matched conditions: CENTRAL NERVOUS SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 03:57 UTC
-
New drug shows promise for rare childhood cancers
Disease control OngoingThis study tests a drug called larotrectinib in children and young adults up to age 30 who have certain cancers (solid tumors or leukemia) with a specific genetic change called a TRK fusion. The goal is to see if the drug can shrink tumors or control the cancer. About 33 particip…
Matched conditions: CENTRAL NERVOUS SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 22, 2026 13:51 UTC